The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
December 2021
in “
Cells
”
alopecia areata Th1 cytokines Th2 cytokines Th17 cytokines IL-2 IFN-γ TNF IL-12 IL-4 IL-6 IL-10 IL-13 IL-17 IL-21 IL-22 IL-23 tofacitinib DPCP AA interleukin-2 interferon-gamma tumor necrosis factor interleukin-12 interleukin-4 interleukin-6 interleukin-10 interleukin-13 interleukin-17 interleukin-21 interleukin-22 interleukin-23 Xeljanz diphenylcyclopropenone
TLDR Alopecia areata severity and treatment response are linked to specific cytokine levels.
The study investigates the role of serum Th1, Th2, and Th17 cytokines in patients with alopecia areata (AA) and their clinical implications. It finds that AA is characterized by elevated levels of Th1 cytokines (IL-2, IFN-γ, TNF, IL-12), Th2 cytokines (IL-4, IL-6, IL-10, IL-13), and Th17 cytokines (IL-17, IL-21, IL-22, IL-23), which correlate with disease severity and duration. Elevated cytokine levels are linked to increased risks of metabolic syndrome, cardiovascular diseases, and depression. Treatments like tofacitinib and DPCP can normalize cytokine levels, suggesting their role in disease pathogenesis and potential as therapeutic targets. The study emphasizes the importance of understanding cytokine profiles in developing personalized treatments for AA patients.